[go: up one dir, main page]

NO20031249L - Emulsjonspreparater samt konsentrater derav - Google Patents

Emulsjonspreparater samt konsentrater derav

Info

Publication number
NO20031249L
NO20031249L NO20031249A NO20031249A NO20031249L NO 20031249 L NO20031249 L NO 20031249L NO 20031249 A NO20031249 A NO 20031249A NO 20031249 A NO20031249 A NO 20031249A NO 20031249 L NO20031249 L NO 20031249L
Authority
NO
Norway
Prior art keywords
vitamin
composition
optionally
drug
emulsion
Prior art date
Application number
NO20031249A
Other languages
English (en)
Other versions
NO20031249D0 (no
NO340515B1 (no
Inventor
Jimmy Hirschsprung Schlyter
Jan Yngvar Piene
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031249(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0023068A external-priority patent/GB0023068D0/en
Priority claimed from GBGB0023069.8A external-priority patent/GB0023069D0/en
Priority claimed from GB0023067A external-priority patent/GB0023067D0/en
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO20031249D0 publication Critical patent/NO20031249D0/no
Publication of NO20031249L publication Critical patent/NO20031249L/no
Publication of NO340515B1 publication Critical patent/NO340515B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/80—Emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A23L35/10—Emulsified foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20031249A 2000-09-20 2003-03-18 Emulsjonspreparater samt konsentrater derav NO340515B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0023068A GB0023068D0 (en) 2000-09-20 2000-09-20 Method
GBGB0023069.8A GB0023069D0 (en) 2000-09-20 2000-09-20 Formulation
GB0023067A GB0023067D0 (en) 2000-09-20 2000-09-20 Composition
PCT/GB2001/004231 WO2002024165A2 (en) 2000-09-20 2001-09-20 Preparation of vitamin emulsions and concentrates thereof

Publications (3)

Publication Number Publication Date
NO20031249D0 NO20031249D0 (no) 2003-03-18
NO20031249L true NO20031249L (no) 2003-05-20
NO340515B1 NO340515B1 (no) 2017-05-02

Family

ID=27255898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031249A NO340515B1 (no) 2000-09-20 2003-03-18 Emulsjonspreparater samt konsentrater derav

Country Status (17)

Country Link
US (1) US20040043043A1 (no)
EP (1) EP1320356B2 (no)
CN (1) CN1461210A (no)
AT (1) ATE380541T1 (no)
AU (1) AU2001287918A1 (no)
BG (1) BG66237B1 (no)
CZ (1) CZ2003808A3 (no)
DE (1) DE60131862D1 (no)
DK (1) DK1320356T4 (no)
EA (1) EA006141B1 (no)
EE (1) EE200300109A (no)
HU (1) HUP0301250A2 (no)
NO (1) NO340515B1 (no)
PL (1) PL365047A1 (no)
PT (1) PT1320356E (no)
SK (1) SK3232003A3 (no)
WO (1) WO2002024165A2 (no)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE319328T1 (de) * 2001-10-19 2006-03-15 Vita Power Ltd Nahrungsmittelzusatzstoff und verfahren zur herstellung eines nahrungsmittelzusatzstoffes
US7560123B2 (en) * 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
KR20040098023A (ko) 2002-03-26 2004-11-18 테바 파마슈티컬 인더스트리즈 리미티드 약물 미세입자
ES2355890T3 (es) 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
EP1526837A1 (de) * 2002-07-24 2005-05-04 Basf Aktiengesellschaft Suspensionen von salzen der ascorbinsäure und ihre verwendung als antioxidantien
US8617617B2 (en) 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7404489B1 (en) * 2003-03-04 2008-07-29 Qol Medical, Llc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20050069627A1 (en) * 2003-03-27 2005-03-31 Mysore Nagaraja Rao Ramesh Process for preparation of fructooligosaccharides (FOS)
FR2859603B1 (fr) * 2003-09-11 2005-12-30 Christian Fenioux Utilisation de la neohesperidine dihydrochalcone dans des compositions orales comprenant des vitamines et/ou des mineraux
MXPA06009506A (es) * 2004-02-19 2007-03-26 San Ei Gen Ffi Inc Agente reductor de nicotina y metodo reductor de nicotina.
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
DE102004043824A1 (de) * 2004-09-10 2006-03-16 Cognis Ip Management Gmbh Emulsionen mit ungesättigten Fettsäuren und deren Estern
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
DE102004046026A1 (de) * 2004-09-21 2006-03-23 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide
AU2005325827C1 (en) * 2005-01-31 2014-01-09 Société des Produits Nestlé S.A. Process for preparing nutritional products
US20070111964A1 (en) 2005-08-17 2007-05-17 Fleming And Company, Pharmaceuticals Vitamin B12 nasal spray and method of use
US8153180B2 (en) * 2005-09-06 2012-04-10 Pepsico, Inc. Method and apparatus for making beverages
GB0601498D0 (en) 2006-01-25 2006-03-08 Probio Nutraceuticals As Product
MX2008012794A (es) * 2006-04-03 2008-10-15 Teva Pharma Microparticulas de farmacos.
AU2006344733B2 (en) * 2006-06-23 2014-02-27 Par Pharmaceutical, Inc. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
AU2014202415B2 (en) * 2006-06-23 2016-02-18 Par Pharmaceutical, Inc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US9364461B2 (en) 2006-12-21 2016-06-14 Santen Sas Process for manufacturing ophthalmic oil-in-water emulsions
US20080227892A1 (en) * 2007-03-13 2008-09-18 Van Der Wielen Maarten Paint formulations comprising cellulose ether/network building polymer fluid gel thickeners
AR066076A1 (es) * 2007-04-18 2009-07-22 Sandoz Ag Procedimiento para dosificar sistemas de liberacion de farmacos auto-emulsionantes
CN103190631B (zh) 2008-03-20 2016-01-20 维尔恩公司 非水性预乳液组合物及制备包含植物甾醇的饮料的方法
AU2009226019C1 (en) 2008-03-20 2014-02-20 Virun, Inc. Emulsions including a PEG-derivative of tocopherol
TR200802713A2 (tr) * 2008-04-18 2009-11-23 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. Demir eksikliği tedavisi için demir çinko esaslı bir farmasötik formülasyon
FR2933868B1 (fr) * 2008-07-21 2012-08-17 Oreal Compositions cosmetiques
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
CN101612120B (zh) * 2008-12-16 2011-02-02 海南美大制药有限公司 氟罗沙星冻干乳剂及其生产方法
US20100158998A1 (en) * 2008-12-23 2010-06-24 Michael Fox Formulations comprising vitamin d or derivatives thereof
US8663728B2 (en) * 2009-07-21 2014-03-04 Cp Kelco U.S., Inc. Protein stabilizer systems comprising carrageenan for weakly acidic flavored milk drinks
GB2475934A (en) * 2009-12-02 2011-06-08 Fit Bioceuticals Pty Ltd Liquid composition comprising vitamin D
CN103037708B (zh) 2010-03-23 2015-05-20 维尔恩公司 含有蔗糖脂肪酸酯的纳米乳液
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
WO2011153513A2 (en) 2010-06-03 2011-12-08 Latitude Pharma Nanoemulsion composition containing vitamin k
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2013059729A1 (en) * 2011-10-21 2013-04-25 First Tech International Limited Tocotrienol compositions
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013114003A1 (fr) * 2012-01-30 2013-08-08 Laboratoires Urgo Procede de preparation d'un produit sirupeux comprenant des vitamines
WO2013120025A1 (en) 2012-02-10 2013-08-15 Virun, Inc. Beverage compositions containing non-polar compounds
WO2013142482A1 (en) * 2012-03-20 2013-09-26 Particle Dynamics International, Llc Gelling agent-based dosage form
US10335540B2 (en) * 2012-04-17 2019-07-02 Micrel Medical Devices S.A. Pharmaceutical blend infusion thereof and Parkinson's disease monitoring system
RU2496332C1 (ru) * 2012-06-14 2013-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уральский государственный экономический университет" (ФГБОУ ВПО "УрГЭУ") Способ изготовления желейной кондитерской массы
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
NL2010550C2 (en) * 2012-11-30 2014-06-04 Klaas Alouis Riepma An intranasal pharmaceutical composition containing vitamin b12.
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
EA026289B1 (ru) * 2013-12-19 2017-03-31 Зао "Эвалар" Биологически активная добавка к пище в форме коллоида
HK1222320A1 (zh) 2013-12-20 2017-06-30 辉瑞大药厂 用於治疗肛门直肠刺激和障碍的预先润湿的擦拭物
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10314857B2 (en) * 2014-07-02 2019-06-11 Virginia Commonwealth University Compositions and methods for treating carbon monoxide and/or cyanide poisoning
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
US20170258791A1 (en) * 2014-08-29 2017-09-14 Project Pm Co., Ltd. Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound
CA2961410C (en) 2014-09-16 2023-07-11 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US10947429B2 (en) 2014-12-23 2021-03-16 Ecosynthetix Inc. Biopolymer and isocyanate based binder and composite materials
EP3247359A4 (en) 2015-01-25 2018-08-08 India Globalization Capital, Inc. Composition and method for treating seizure disorders
PL3628398T3 (pl) * 2015-01-28 2021-12-20 Fona Technologies, Llc Sposób wytwarzania kapsułkowanego produktu i kapsułkowany produkt
WO2016130908A1 (en) 2015-02-13 2016-08-18 The University Of Toledo Therapeutic polysaccharide midi-gagr and related materials and methods
SG11201706283UA (en) 2015-03-12 2017-09-28 Givaudan Sa Emulsions
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10596159B2 (en) 2015-08-12 2020-03-24 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
EP3471746A4 (en) 2016-06-15 2020-02-26 India Globalization Capital, Inc. METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS
US12179379B2 (en) 2017-06-29 2024-12-31 Ecosynthetix Inc. Adhesive with tack and use in wood composite products
ES2996558T3 (en) * 2017-10-25 2025-02-12 Fresenius Kabi Deutschland Gmbh All-in-one lyophilized multivitamin emulsion for parenteral application
US11147761B2 (en) 2018-01-12 2021-10-19 Nicole Akmenkalns Topical supplement composition and method of use
CN110123752A (zh) * 2019-06-12 2019-08-16 北京方同顺医药科技有限公司 一种普罗布考干乳剂组合物及其制备方法和制药应用
CN111165824A (zh) * 2020-01-21 2020-05-19 北京金康普食品科技有限公司 护眼微量营养素预混料乳剂及其制备方法和应用
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN111544403A (zh) * 2020-05-13 2020-08-18 吉林吉力生物技术研究有限公司 一种犬用阿托伐醌风味片及其制备方法和应用
CN115558659B (zh) * 2022-10-28 2023-05-12 东北农业大学 一种包埋植物乳杆菌乳剂及其制备方法和应用
GB2636420A (en) 2023-12-13 2025-06-18 Yara Uk Ltd Emulsifiable concentrate comprising vitamin D and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB919193A (en) * 1958-11-12 1963-02-20 Shinshiro Ohtaki A method for producing powder containing oil or fat
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
EP0419885B1 (de) † 1989-08-31 1993-05-19 Paul Resmer Flüssige, stabile Guarkernmehl enthaltende Trink- und Sondennahrung
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
CH681343A5 (no) * 1990-10-26 1993-03-15 Nestle Sa
WO1992014443A1 (en) * 1991-02-20 1992-09-03 Warner-Lambert Company Microsphere-in-oil emulsion
DE69232376T2 (de) * 1991-09-06 2002-09-26 Cognis Australien Pty.Ltd., Victoria Carotinoide zusammensetzung
US5393461A (en) * 1993-10-04 1995-02-28 Rtd Corporation Preparation of stable aqueous emulsions of water-insoluble particles
DE59707063D1 (de) * 1996-03-25 2002-05-23 Bauer Wulf Heilmittel zur äusserlichen anwendung und verwendung einer wässrigen öl-emulsion für ein derartiges heilmittel
ATE238772T1 (de) * 1997-10-07 2003-05-15 Eisai Co Ltd Verfahren zur herstellung von emulgiertem puder
DE19756123A1 (de) * 1997-12-17 1999-06-24 Remedia Pharmazeutische Praepa Diätetische oder pharmazeutische Zubereitung
DE19842744B4 (de) * 1998-09-18 2006-12-21 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl und deren Verwendung
GB9906009D0 (en) * 1999-03-16 1999-05-12 Nycomed Pharma As Product
DE19938757A1 (de) * 1999-08-16 2001-02-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser

Also Published As

Publication number Publication date
AU2001287918A1 (en) 2002-04-02
NO20031249D0 (no) 2003-03-18
US20040043043A1 (en) 2004-03-04
NO340515B1 (no) 2017-05-02
PL365047A1 (en) 2004-12-27
HUP0301250A2 (hu) 2003-11-28
DK1320356T4 (da) 2011-09-12
WO2002024165A3 (en) 2002-12-27
BG107738A (bg) 2004-01-30
CN1461210A (zh) 2003-12-10
BG66237B1 (bg) 2012-08-31
CZ2003808A3 (cs) 2003-08-13
EE200300109A (et) 2005-04-15
DK1320356T3 (da) 2008-01-28
DE60131862D1 (de) 2008-01-24
PT1320356E (pt) 2008-01-03
EP1320356A2 (en) 2003-06-25
EA006141B1 (ru) 2005-10-27
EA200300300A1 (ru) 2003-12-25
EP1320356B2 (en) 2011-06-08
EP1320356B1 (en) 2007-12-12
WO2002024165A2 (en) 2002-03-28
SK3232003A3 (en) 2004-02-03
ATE380541T1 (de) 2007-12-15

Similar Documents

Publication Publication Date Title
NO20031249D0 (no) Emulsjonspreparater samt konsentrater derav
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
ATE415943T1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
AU3787601A (en) New self emulsifying drug delivery system
ATE331024T1 (de) Wasserlösliche packung enthaltend eine flüssige zusammensetzung mit einer visuell unterscheidbaren kapsel oder emulsion oder dispersionsschicht
DE60129134D1 (en) O/w emulsion
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
MY137749A (en) New self emulsifying drug delivery system
ATE322250T1 (de) Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen
PT799035E (pt) Emulsao adequada para administracao de um esfingolipido e respectiva utilizacao
AR028752A1 (es) Composicion adecuada para la preparacion de una emulsion de aceite en agua
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
BR112022004331A2 (pt) Emulsão, usos da emulsão e de um sulfopolímero, método para fabricar uma emulsão, e, adjuvante de emulsificação
DE60123419D1 (de) Flüssige arzneizubereitungen für die orale verabreichung von unangenehm, bitterschmeckenden arzneimitteln
GB2317562A (en) Lipid vehicle drug delivery composition containing vitamin E

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA AS, NO

MK1K Patent expired